APA (7th ed.) Citation

A, K., H, V., D, G., D, B., RD, S., V, V., . . . SM, S. (2025). FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 20(3), 331. https://doi.org/10.1016/j.jtho.2024.11.022

Chicago Style (17th ed.) Citation

A, Kazi, Vasiyani H, Ghosh D, Bandyopadhyay D, Shah RD, Vudatha V, Trevino J, and Sebti SM. "FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer 20, no. 3 (2025): 331. https://doi.org/10.1016/j.jtho.2024.11.022.

MLA (9th ed.) Citation

A, Kazi, et al. "FGTI-2734 Inhibits ERK Reactivation to Overcome Sotorasib Resistance in KRAS G12C Lung Cancer." Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, vol. 20, no. 3, 2025, p. 331, https://doi.org/10.1016/j.jtho.2024.11.022.